The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRotork Regulatory News (ROR)

Share Price Information for Rotork (ROR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 340.60
Bid: 340.40
Ask: 340.80
Change: 2.40 (0.71%)
Spread: 0.40 (0.118%)
Open: 339.60
High: 342.20
Low: 337.00
Prev. Close: 338.20
ROR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Share Buy-Back Programme

21 Mar 2024 07:00

RNS Number : 6892H
Rotork PLC
21 March 2024
 

21 March 2024

 

Rotork plc

Share buy-back programme

 

As announced at the preliminary results on 5 March 2024, Rotork plc ('Rotork' or the 'Company') remains a highly cash generative business with a strong cash position that provides us with considerable financial flexibility. Consistent with our stated capital allocation policy, the Board has decided to return cash to shareholders while retaining a strong balance sheet. As a result, Rotork is commencing a share buyback programme (the 'Programme') to repurchase ordinary shares of 0.5 pence each in the capital of the Company ('Ordinary Shares'). The aggregate purchase price of all Ordinary Shares acquired under the Programme will be no more than £50 million (excluding stamp duty and expenses). Any Ordinary Shares purchased by the Company will be cancelled. Our financial flexibility enables us to pursue strategic investments and we remain active in looking for suitable opportunities, consistent with our Growth+ strategy.

 

The first tranche of the Programme will be carried out through an irrevocable non-discretionary agreement with Morgan Stanley & Co. International Plc ('MS'), pursuant to which MS shall purchase Ordinary Shares as riskless principal (and not as agent of Rotork) for the subsequent sale on to, and purchase by, Rotork. The first tranche of the Programme will run from 21 March 2024 and end no later than 24 May 2024. The aggregate purchase price of all Ordinary Shares acquired under the first tranche of the Programme will be no greater than £10 million (excluding stamp duty and expenses). Any purchases under the Programme will take place in accordance with (and subject to the limits prescribed by) the Company's general authority to repurchase Ordinary Shares granted at the Company's 2023 Annual General Meeting (the "2023 Authority") and any subsequent authority granted at the Company's next Annual General Meeting on 30 April 2024. The maximum number of Ordinary Shares that the Company is authorised to purchase under the 2023 Authority is 86,082,814 Ordinary Shares. MS will make its trading decisions in relation to the Ordinary Shares independently of, and uninfluenced by, the Company.

 

Any purchase of Ordinary Shares in relation to the Programme will be carried out on the London Stock Exchange and any other UK recognised investment exchange which may be agreed, in accordance with pre-set parameters and in accordance with (and subject to limits prescribed by) the Company's general authority to repurchase Ordinary Shares granted by its shareholders at its 2023 Annual General Meeting (or as subsequently granted at the Company's 2024 AGM), Chapter 12 of the Financial Conduct Authority's Listing Rules, Article 5(1) of Regulation (EU) No. 596/2014 (as incorporated into UK domestic law by the European Union (Withdrawal) Act 2018) and Commission Delegated Regulation (EU) 2016/1052 (as incorporated into UK domestic law by the European Union (Withdrawal) Act 2018). Rotork will announce any market repurchases of Ordinary Shares no later than 7.30 a.m. on the business day following the calendar day on which the repurchase occurred.

 

Enquiries:

 

Nick Hasell/Susanne Yule, FTI Consulting Tel: +44 (0) 3727 1340

Andrew Carter, Investor Relations Director, Rotork Plc Tel: +44 (0) 1225 733 200

 

Legal Entity Identifier: 213800AH5RZIHGWRJ718

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFLFSTVAIIFIS
Date   Source Headline
2nd Jul 202011:27 amRNSTotal Voting Rights
30th Jun 20207:00 amRNSPre-close update
12th Jun 20209:28 amRNSDirector/PDMR Shareholding
4th Jun 202010:33 amRNSTotal Voting Rights
1st Jun 20204:00 pmRNSDirector/PDMR Shareholding
22nd May 20204:07 pmRNSDirector/PDMR Shareholding
13th May 20203:47 pmRNSDirector/PDMR Shareholding
13th May 20209:35 amRNSDisclosure of rights attached to equity shares
1st May 20208:10 amRNSTotal Voting Rights
24th Apr 20201:34 pmRNSResult of AGM
17th Apr 20203:13 pmRNSAnnual General Meeting 2020 Update
15th Apr 20204:50 pmRNSDirector/PDMR Shareholding
9th Apr 20202:14 pmRNSHolding(s) in Company
9th Apr 202012:54 pmRNS2020 LTIP awards and Remuneration Update
6th Apr 202010:08 amRNSCompany Secretary Change
3rd Apr 202011:36 amRNSDirector Declaration
2nd Apr 20205:18 pmRNSTotal Voting Rights
2nd Apr 20205:08 pmRNSHolding(s) in Company
1st Apr 20209:00 amRNSNotice of AGM
31st Mar 20207:00 amRNSResponding to COVID-19
17th Mar 20205:07 pmRNSDirector/PDMR Shareholding
13th Mar 20203:56 pmRNSDirector/PDMR Shareholding
12th Mar 20203:05 pmRNSDirector/PDMR Shareholding
11th Mar 20204:55 pmRNSDirector/PDMR Shareholding
6th Mar 20204:30 pmRNSHolding(s) in Company
4th Mar 20203:29 pmRNSDirector Declaration
4th Mar 20207:00 amRNSHolding(s) in Company
3rd Mar 20201:30 pmRNSTotal Voting Rights
3rd Mar 20207:00 amRNS2019 Full Year Results
28th Feb 20208:14 amRNSDirector Declaration
14th Feb 20203:14 pmRNSDirector/PDMR Shareholding
3rd Feb 20201:17 pmRNSTotal Voting Rights
13th Jan 20203:05 pmRNSDirector/PDMR Shareholding
2nd Jan 202011:09 amRNSTotal Voting Rights
20th Dec 20192:39 pmRNSDirector/PDMR Shareholding
20th Dec 201912:41 pmRNSDirector/PDMR Shareholding
2nd Dec 20195:02 pmRNSTotal Voting Rights
21st Nov 20192:05 pmRNSDirector/PDMR Shareholding
21st Nov 20197:00 amRNSTrading Update
14th Nov 201910:07 amRNSHolding(s) in Company
13th Nov 201910:39 amRNSDirector/PDMR Shareholding
6th Nov 20194:13 pmRNSHolding(s) in Company
5th Nov 20197:30 amRNSDirector Declaration
1st Nov 20191:44 pmRNSTotal Voting Rights
21st Oct 20191:36 pmRNSDirector/PDMR Shareholding
15th Oct 20193:53 pmRNSDirector/PDMR Shareholding
1st Oct 20197:00 amRNSTotal Voting Rights
30th Sep 201911:28 amRNSDirector Declaration
23rd Sep 201910:58 amRNSDirector/PDMR Shareholding
13th Sep 20193:35 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.